However, after G-MDSCs were completely depleted, the cytotoxicity of CD8+ T cells and the inhibitory effect of MDSCs had no significant difference between ZQT group and the control group, suggesting that the anti-tumor activity of ZQT was achieved by targeting G-MDSCs subset (39). The gene discussed is CD8A; the disease is neoplasm.